1. Home
  2. TWN vs GNFT Comparison

TWN vs GNFT Comparison

Compare TWN & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWN
  • GNFT
  • Stock Information
  • Founded
  • TWN 1986
  • GNFT 1999
  • Country
  • TWN Hong Kong
  • GNFT France
  • Employees
  • TWN N/A
  • GNFT N/A
  • Industry
  • TWN Trusts Except Educational Religious and Charitable
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TWN Finance
  • GNFT Health Care
  • Exchange
  • TWN Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • TWN 313.8M
  • GNFT 296.4M
  • IPO Year
  • TWN N/A
  • GNFT 2019
  • Fundamental
  • Price
  • TWN $43.08
  • GNFT $4.50
  • Analyst Decision
  • TWN
  • GNFT Strong Buy
  • Analyst Count
  • TWN 0
  • GNFT 1
  • Target Price
  • TWN N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • TWN 20.1K
  • GNFT 6.3K
  • Earning Date
  • TWN 01-01-0001
  • GNFT 09-19-2024
  • Dividend Yield
  • TWN 1.10%
  • GNFT N/A
  • EPS Growth
  • TWN N/A
  • GNFT N/A
  • EPS
  • TWN N/A
  • GNFT 0.47
  • Revenue
  • TWN N/A
  • GNFT $86,225,222.00
  • Revenue This Year
  • TWN N/A
  • GNFT $155.44
  • Revenue Next Year
  • TWN N/A
  • GNFT N/A
  • P/E Ratio
  • TWN N/A
  • GNFT $9.31
  • Revenue Growth
  • TWN N/A
  • GNFT 175.45
  • 52 Week Low
  • TWN $25.22
  • GNFT $3.08
  • 52 Week High
  • TWN $41.51
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • TWN 41.14
  • GNFT 28.81
  • Support Level
  • TWN $42.10
  • GNFT $5.10
  • Resistance Level
  • TWN $45.96
  • GNFT $5.81
  • Average True Range (ATR)
  • TWN 0.93
  • GNFT 0.21
  • MACD
  • TWN -0.26
  • GNFT -0.16
  • Stochastic Oscillator
  • TWN 25.32
  • GNFT 6.13

About TWN Taiwan Fund Inc. (The)

Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: